相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Modulating calcium-mediated NFATc1 and mitogen-activated protein kinase deactivation underlies the inhibitory effects of kavain on osteoclastogenesis and bone resorption
Qiang Guo et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Activation of Nrf2 Pathway Contributes to Neuroprotection by the Dietary Flavonoid Tiliroside
Ravikanth Velagapudi et al.
MOLECULAR NEUROBIOLOGY (2018)
Tectorigenin inhibits RANKL-induced osteoclastogenesis via suppression of NF-κB signalling and decreases bone loss in ovariectomized C57BL/6
Chiyuan Ma et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Platycodin D Inhibits Osteoclastogenesis by Repressing the NFATc1 and MAPK Signaling Pathway
Jae Ho Choi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
Matrine prevents bone loss in ovariectomized mice by inhibiting RANKL-induced osteoclastogenesis
Xiao Chen et al.
FASEB JOURNAL (2017)
The many ways of osteoclast activation
Joseph Lorenzo
JOURNAL OF CLINICAL INVESTIGATION (2017)
Molecularly imprinted polymers for the selective extraction of tiliroside from the flowers of Edgeworthia gardneri (wall.) Meisn
Die Gao et al.
JOURNAL OF SEPARATION SCIENCE (2017)
Isolation of natural products with anti-ageing activity from the fruits of Platanus orientalis
Sofia Chatzigeorgiou et al.
PHYTOMEDICINE (2017)
Osteoporosis treatment: recent developments and ongoing challenges
Sundeep Khosla et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Mechanism of the Antihypertensive and Vasorelaxant Effects of the Flavonoid Tiliroside in Resistance Arteries
Grazielle C. Silva et al.
PLANTA MEDICA (2013)
Nicotine Affects Bone Resorption and Suppresses the Expression of Cathepsin K, MMP-9 and Vacuolar-Type H+-ATPase d2 and Actin Organization in Osteoclasts
Hideki Tanaka et al.
PLOS ONE (2013)
A novel small molecule, NecroX-7, inhibits osteoclast differentiation by suppressing NF-κB activity and c-Fos expression
Hyun-Ju Kim et al.
LIFE SCIENCES (2012)
Osteoporosis: now and the future
Tilman D. Rachner et al.
LANCET (2011)
Cohort Profile: Research on Osteoarthritis/Osteoporosis Against Disability study
Noriko Yoshimura et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2010)
NF-κB modulators in osteolytic bone diseases
Jiake Xu et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2009)
Cathepsin K Activity-dependent Regulation of Osteoclast Actin Ring Formation and Bone Resorption
Susan R. Wilson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Myocyte Enhancer Factor 2 and Microphthalmia-associated Transcription Factor Cooperate with NFATc1 to Transactivate the V-ATPase d2 Promoter during RANKL-induced Osteoclastogenesis
HaoTian Feng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Diphenylhydantoin Inhibits Osteoclast Differentiation and Function Through Suppression of NFATc1 Signaling
Masanori Koide et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Receptor activator of nuclear factor kappa B ligand and osteoprotegerin regulation of bone remodeling in health and disease
Ann E. Kearns et al.
ENDOCRINE REVIEWS (2008)
The roles of the classical and alternative nuclear factor-kappa B pathways: potential implications for autoimmunity and rheumatoid arthritis
Keith D. Brown et al.
ARTHRITIS RESEARCH & THERAPY (2008)
Tiliroside and gnaphaliin inhibit human low density lipoprotein oxidation
Guillermo R. Schinella et al.
FITOTERAPIA (2007)
Effects of conjugated equine estrogen on risk of fractures and BMD in postmenopausal women with hysterectomy: Results from the women's health initiative randomized trial
Rebecca D. Jackson et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Thapsigargin modulates osteoclastogenesis through the regulation of RANKL-induced signaling pathways and reactive oxygen species production
KHM Yip et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation
NK Lee et al.
BLOOD (2005)
Gefitinib inhibits the ability of human bone marrow stromal cells to induce osteoclast differentiation: implications for the pathogenesis and treatment of bone metastasis
N Normanno et al.
ENDOCRINE-RELATED CANCER (2005)
Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos
K Matsuo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Overview of osteoporosis: pathophysiology and determinants of bone strength
CM Bono et al.
EUROPEAN SPINE JOURNAL (2003)
Osteoclast differentiation and activation
WJ Boyle et al.
NATURE (2003)
Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo
J Cornish et al.
JOURNAL OF ENDOCRINOLOGY (2002)
Troglitazone treatment increases bone marrow adipose tissue volume but does not affect trabecular bone volume in mice
L Tornvig et al.
CALCIFIED TISSUE INTERNATIONAL (2001)
ERK5 and ERK2 cooperate to regulate NF-κB and cell transformation
G Pearson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Human osteoclast cathepsin K is processed intracellularly prior to attachment and bone resorption
RA Dodds et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
Cloning, sequencing, and functional characterization of the rat homologue of receptor activator of NF-κB ligand
JK Xu et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2000)
分享论文
